A Quick Look at Today's Ratings for Black Diamond Therapeutics(BDTX.US), With a Forecast Between $11 to $18

Moomoo NewsSep 24 09:00 ET · Ratings

Buy Rating on Black Diamond Therapeutics: Promising Phase 2 Results for BDTX-1535 in NSCLC Treatment

TipRanksSep 24 06:25 ET · Ratings

Black Diamond Theraptcs Is Maintained at Overweight by Piper Sandler

Dow JonesSep 23 14:11 ET · Ratings

US Equity Futures Gain as Investors Search for Fresh Catalysts After Fed Rate Cut

MT NewswiresSep 23 09:06 ET

Sector Update: Health Care

MT NewswiresSep 23 08:48 ET

Market-Moving News for September 23rd

BenzingaSep 23 08:10 ET